09/23/2022
8:01 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2022
5:09 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2022
5:05 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2022
6:47 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2022
6:38 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2022
4:11 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
4:08 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
4:06 PM | Intra-Cellular Therapies (Issuer)
Rawlins Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
4:03 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
4:01 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/13/2022
4:01 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2022
4:24 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2022
6:46 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2022
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2022
6:12 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2022
4:04 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A
| |
04/21/2022
4:01 PM | Intra-Cellular Therapies (Filer)
| Form DEF 14A
| |
04/21/2022
3:54 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2022
3:52 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/21/2022
7:08 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2021
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2021
6:31 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2021
3:34 PM | Intra-Cellular Therapies (Issuer)
Rawlins Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2021
3:30 PM | Intra-Cellular Therapies (Issuer)
Rawlins Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/22/2021
3:26 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2021
3:23 PM | Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2021
3:21 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2021
4:02 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
3:05 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
3:02 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2021
5:00 PM | Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2021
5:02 PM | Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2021
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2021
6:31 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2021
6:42 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/20/2021
6:07 AM | Intra-Cellular Therapies (Filer)
| Form DEFA14A
| |
04/19/2021
4:28 PM | Intra-Cellular Therapies (Filer)
| Form PRE 14A
| |
04/02/2021
4:31 PM | Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
4:29 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
4:27 PM | Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
4:26 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2021
4:43 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:28 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:24 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:20 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:12 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
6:54 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2021
6:46 AM | Intra-Cellular Therapies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2021
7:09 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:07 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/22/2021
7:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:03 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:09 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2021
4:18 PM | BB BIOTECH AG (Filed by)
Intra-Cellular Therapies (Subject)
| Form SC 13G/A
| |
02/10/2021
10:03 AM | Intra-Cellular Therapies (Subject)
| Form SC 13G/A
| |
02/09/2021
2:23 PM | Intra-Cellular Therapies (Subject)
WASATCH ADVISORS INC (Filed by)
| Form SC 13G
| |
02/08/2021
9:25 AM | FMR LLC (Filed by)
Intra-Cellular Therapies (Subject)
| Form SC 13G/A
| |
01/29/2021
8:57 AM | BlackRock Inc. (Filed by)
Intra-Cellular Therapies (Subject)
| Form SC 13G/A
| |
01/12/2021
6:07 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2021
6:06 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2021
6:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2021
6:03 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2021
6:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:13 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:11 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:09 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:07 PM | Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:05 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:03 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:01 PM | Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2020
3:03 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
3:07 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2020
7:05 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2020
4:51 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2020
4:51 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2020
6:45 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020
6:40 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2020
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
3:02 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2020
3:04 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2020
3:17 PM | Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2020
3:13 PM | Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2020
3:38 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2020
4:03 PM | Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2020
6:08 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2020
3:47 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2020
3:44 PM | Intra-Cellular Therapies (Filer)
| Form 424B5
| |
09/11/2020
3:15 PM | Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
3:02 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
4:26 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
3:40 PM | Intra-Cellular Therapies (Filer)
| Form 424B5
| |
09/09/2020
6:13 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
3:16 PM | Intra-Cellular Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/10/2020
7:17 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2020
6:52 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2020
4:48 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2020
6:12 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2020
6:05 PM | Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2020
6:02 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
